MedTrace Logo

The Amager Project: Intervention After Suicide Attempt

NCT00821756 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2009-01-13

No results posted yet for this study

Summary

Background:

Repetition rate after a suicide attempt and self harm is very high, about 12-30 percent. Studies, reviewed by Hawton, 1999 show a lack of evidence for psychosocial interventions. Compliance with aftercare is also often very poor.

Objective:

Inspired by the Norwegian Baerum project, the aim is to study if active, assertive outreach, seeking contact, talking about problem solution, motivate to comply to other appointments, will reduce repetition of suicidal acts in the following years.

Methods:

The design is a prospective randomized, controlled trial. The patients (immediately after a suicide attempt or deliberate self harm)) included are randomized to intervention or standard (treatment as usual), aiming at at least 60 persons in each arm. The intervention is carried out through research nurses with about 8 home visits, phone contact, phone messaging, e-mails.Included are persons 12 years of age and older, danish speaking without translator and without diagnoses of severe mental illness (schizophrenia, bipolar illness, mania and severe/psychotic depression) or severe dementia.

Results:

Outcome is measured by repetition of suicidal act (suicide attempt, self harm or completed suicide)as recorded in medical records and by the Danish Cause of Death Register. Repetition measured by persons and by acts throughout 1 year, 2 and 3 years periods. Additional outcome is number and character of health system contacts.

Conditions

  • Suicidal Behaviour
  • Repetition of Suicidal Behaviour

Interventions

BEHAVIORAL

OPAC (Outreach, Problem solving, Adherence, Continuity)

Assertive outreach immediately after the suicide attempt with about 8 home visits plus contact by telephone, phone messages, e-mails. Duration of intervention 6 months.

Sponsors & Collaborators

  • Ministry of Social Affairs, Denmark

    collaborator OTHER_GOV

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • August G. Wang, M.D. · Psychiatric Centre Amager, Copenhagen University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-08-31
Completion
2010-08-31

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00821756 on ClinicalTrials.gov